A Smart Self-Management Support Programme (3S) to Improve Quality of Life in Lung Cancer Patients
1 other identifier
interventional
320
1 country
3
Brief Summary
Lung cancers patients often experience multiple symptoms (e.g. fatigue, dyspnea, distress, depression, sleep disturbance). The current study attempts to explore the efficacy of the Smart Self-Management Support Programme (3S) in improving quality of life of patients using self-management support programme with mobile devices.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable lung-cancer
Started Apr 2024
3 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
April 9, 2024
CompletedFirst Posted
Study publicly available on registry
April 22, 2024
CompletedStudy Start
First participant enrolled
April 22, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
March 31, 2026
CompletedStudy Completion
Last participant's last visit for all outcomes
June 30, 2026
ExpectedMarch 19, 2025
March 1, 2025
1.9 years
April 9, 2024
March 14, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Change in health-related quality of life
Measured by a 30-item European Organization for Research and Treatment of Cancer and Lung Module. All scale scores are linearly converted to a range from 0 to 100. Higher scores indicate better functioning and quality of life.
Baseline and 8-week follow-up
Secondary Outcomes (25)
Change in health-related quality of life
Baseline and 24-week follow-up
Change in patient activation
Baseline, 8-week and 24-week follow-up
Change in general self-efficacy
Baseline, 8-week and 24-week follow-up
Change in acceptance of illness
Baseline, 8-week and 24-week follow-up
Change in physical activity level
Baseline, 8-week and 24-week follow-up
- +20 more secondary outcomes
Study Arms (2)
The 3S intervention group
EXPERIMENTALReceive information and support on self-management of lung cancer
The GH information group
PLACEBO COMPARATORReceive general health information such as sleep hygiene, environmental hygiene, etc.
Interventions
The 3S intervention includes information and support related to self-management of lung cancer, including 1. an individual 3S session at baseline, 2. 24-week messaging, telephone coaching and hotline services.
The GH information includes information related to general health, including 1. an individual GH session at baseline, 2. 24-week messaging, telephone coaching and hotline services.
Eligibility Criteria
You may qualify if:
- Aged 18 years or above
- Diagnosis of advanced-stage (stage III or stage IV) non-small cell lung cancer
- Ambulatory and capable of all self-care activities (ECOG ≤2)
- Either undergoing or has finished oncology therapy
- Mentally, cognitively and physically fit to join as determined by the doctor in charge and responsible clinical investigators
- Can speak and read Chinese
- Willing to complete the patient-reported outcome questionnaire
- Has a smartphone with WhatsApp or WeChat
You may not qualify if:
- Preparing for lung operation
- Skeletal fragility
- Serious active infection
- Inability to walk
- Previously untreated symptomatic brain metastases
- Severe respiratory insufficiency
- Uncontrolled pain
- Diagnosed psychiatric illness with or without medication
- Family Caregivers:
- Aged 18 years or above
- Family caregivers of recruited patients
- Unable to speak and read Chinese
- Unwilling to complete the patient-reported outcome questionnaire
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- The University of Hong Konglead
- Queen Mary Hospital, Hong Kongcollaborator
- The Queen Elizabeth Hospitalcollaborator
- United Christian Hospitalcollaborator
Study Sites (3)
Queen Elizabeth Hospital
Hong Kong, Ho ManTin, Hong Kong
Queen Mary Hospital
Hong Kong, Hong Kong
United Christian Hospital
Hong Kong, Hong Kong
Related Publications (5)
Kondylakis H, Bucur A, Crico C, Dong F, Graf N, Hoffman S, Koumakis L, Manenti A, Marias K, Mazzocco K, Pravettoni G, Renzi C, Schera F, Triberti S, Tsiknakis M, Kiefer S. Patient empowerment for cancer patients through a novel ICT infrastructure. J Biomed Inform. 2020 Jan;101:103342. doi: 10.1016/j.jbi.2019.103342. Epub 2019 Dec 6.
PMID: 31816400BACKGROUNDSaetan P, Chaiviboontham S, Pokpalagon P, Chansriwong P. The Effects of the Respiratory Rehabilitation Program on Perceived Self-Efficacy and Dyspnea in Patients with Lung Cancer. Asian Nurs Res (Korean Soc Nurs Sci). 2020 Dec;14(5):277-285. doi: 10.1016/j.anr.2020.08.010. Epub 2020 Sep 8.
PMID: 32916339BACKGROUNDZhu X, Han S, Chu H, Wang M, Chen S. Influence of self-management exercise intervention on the cancer related fatigue severity and self-management efficacy of patients with non-small cell lung cancer after operation. J Pak Med Assoc. 2020 Sep;70 [Special Issue](9):88-93.
PMID: 33177734BACKGROUNDHernandez Silva E, Lawler S, Langbecker D. The effectiveness of mHealth for self-management in improving pain, psychological distress, fatigue, and sleep in cancer survivors: a systematic review. J Cancer Surviv. 2019 Feb;13(1):97-107. doi: 10.1007/s11764-018-0730-8. Epub 2019 Jan 11.
PMID: 30635865BACKGROUNDJi W, Kwon H, Lee S, Kim S, Hong JS, Park YR, Kim HR, Lee JC, Jung EJ, Kim D, Choi CM. Mobile Health Management Platform-Based Pulmonary Rehabilitation for Patients With Non-Small Cell Lung Cancer: Prospective Clinical Trial. JMIR Mhealth Uhealth. 2019 Jun 21;7(6):e12645. doi: 10.2196/12645.
PMID: 31228180BACKGROUND
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Agnes Yuen Kwan Lai, PhD
School of Nursing and Health Sciences
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- OUTCOMES ASSESSOR
- Masking Details
- The outcome assessor was not aware of which groups the patients belonged to.
- Purpose
- SUPPORTIVE CARE
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Honorary Assistant Professor
Study Record Dates
First Submitted
April 9, 2024
First Posted
April 22, 2024
Study Start
April 22, 2024
Primary Completion
March 31, 2026
Study Completion (Estimated)
June 30, 2026
Last Updated
March 19, 2025
Record last verified: 2025-03
Data Sharing
- IPD Sharing
- Will not share
For those who want the patient data, please contact PI directly by written email.